Methamphetamine (Simple English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Methamphetamine" in Simple English language version.

Last modified: 21:31:51, 23 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Simple English rank

3112nih.gov

5^th place

2720web.archive.org

1^st place

227doi.org

2^nd place

153semanticscholar.org

15^th place

11^th place

74drugabuse.gov

low place

1,791^st place

72worldcat.org

4^th place

6^th place

22fda.gov

470^th place

788^th place

21usdoj.gov

4,271^st place

2,818^th place

21justice.gov

884^th place

644^th place

11lexico.com

2,946^th place

848^th place

11in.gov.br

3,835^th place

7,066^th place

11adsabs.harvard.edu

14^th place

17^th place

11archive.org

6^th place

3^rd place

11house.gov

501^st place

230^th place

11illinoisattorneygeneral.gov

low place

11projectknow.com

low place

11drugabuse.com

low place

8,590^th place

11drugrehab.ca

low place

11healthvermont.gov

low place

adsabs.harvard.edu (Global: 14^th place; Simple English: 17^th place)

ui.adsabs.harvard.edu

Sellers EM, Tyndale RF (2000). "Mimicking gene defects to treat drug dependence". Ann. N. Y. Acad. Sci. 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. S2CID 27787938. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.

archive.org (Global: 6^th place; Simple English: 3^rd place)

Cashman JR, Xiong YN, Xu L, Janowsky A (March 1999). "N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication". J. Pharmacol. Exp. Ther. 288 (3): 1251–1260. doi:10.1016/S0022-3565(24)38081-4. PMID 10027866.

doi.org (Global: 2^nd place; Simple English: 2^nd place)

Cruickshank CC, Dyer KR (July 2009). "A review of the clinical pharmacology of methamphetamine". Addiction. 104 (7): 1085–1099. doi:10.1111/j.1360-0443.2009.02564.x. PMID 19426289. S2CID 37079117.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327. S2CID 42588722.
Courtney KE, Ray LA (October 2014). "Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature". Drug Alcohol Depend. 143: 11–21. doi:10.1016/j.drugalcdep.2014.08.003. PMC 4164186. PMID 25176528.
Rau T, Ziemniak J, Poulsen D (2015). "The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury". Prog. Neuropsychopharmacol. Biol. Psychiatry. 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. ISSN 0278-5846. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).
Sellers EM, Tyndale RF (2000). "Mimicking gene defects to treat drug dependence". Ann. N. Y. Acad. Sci. 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. S2CID 27787938. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.
Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Krueger SK, Williams DE (2005). "Table 5: N-containing drugs and xenobiotics oxygenated by FMO". Pharmacology & Therapeutics. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018. Archived from the original on 16 September 2018.
Cashman JR, Xiong YN, Xu L, Janowsky A (March 1999). "N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication". J. Pharmacol. Exp. Ther. 288 (3): 1251–1260. doi:10.1016/S0022-3565(24)38081-4. PMID 10027866.

drugabuse.com (Global: low place; Simple English: 8,590^th place)

"Effects of Meth on the Body | What Does Meth Do to Your Body?". DrugAbuse.com. Archived from the original on 2021-08-21. Retrieved 2021-08-21.

drugabuse.gov (Global: low place; Simple English: 1,791^st place)

drugabuse.gov

"NIDA – Research Report Series – Methamphetamine Abuse and Addiction". drugabuse.gov. Archived from the original on December 16, 2010. Retrieved January 22, 2011.
"NIDA – Research Report Series – Methamphetamine Abuse and Addiction". drugabuse.gov. Archived from the original on January 12, 2011. Retrieved January 22, 2011.
"DrugFacts: Methamphetamine". www.drugabuse.gov. U.S. National Institute on Drug Abuse. January 2014. Archived from the original on January 2, 2016. Retrieved December 31, 2015.

archives.drugabuse.gov

"CEWG Publications – 6/99 Seattle Advance Report – Epidemiologic Trends in Drug Abuse – NIDA". archives.drugabuse.gov. Archived from the original on August 18, 2011. Retrieved January 23, 2011.

drugrehab.ca (Global: low place; Simple English: low place)

"WHAT IS THE LIFE EXPECTANCY OF A METHAMPHETAMINE ADDICT?". DRS. Archived from the original on 18 May 2016. Retrieved 18 January 2016.

fda.gov (Global: 470^th place; Simple English: 788^th place)

accessdata.fda.gov

"Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. Shire US Inc. December 2013. pp. 12–13. Archived (PDF) from the original on 30 December 2013. Retrieved 30 December 2013.
"DESOXYN" (PDF). accessdata.fda.gov. Food and Drug Administration. pp. 1, 7. Archived (PDF) from the original on March 11, 2011. Retrieved January 20, 2011.

healthvermont.gov (Global: low place; Simple English: low place)

"Signs of Methamphetamine use in youths – Alcohol and Drug Abuse Information – Vermont Department of Health". healthvermont.gov. Archived from the original on November 26, 2010. Retrieved January 23, 2011.

house.gov (Global: 501^st place; Simple English: 230^th place)

"CRS Report for Congress" (PDF). house.gov. May 22, 2006. Archived from the original (PDF) on May 5, 2009. Retrieved January 20, 2011.

illinoisattorneygeneral.gov (Global: low place; Simple English: low place)

"Illinois Attorney General – Basic Understanding Of Meth". illinoisattorneygeneral.gov. Archived from the original on September 10, 2010. Retrieved January 23, 2011.

in.gov.br (Global: 3,835^th place; Simple English: 7,066^th place)

Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 27 August 2023. Retrieved 27 August 2023.

justice.gov (Global: 884^th place; Simple English: 644^th place)

"Methamphetamine Fast Facts". justice.gov. Archived from the original on July 25, 2010. Retrieved January 23, 2011.

lexico.com (Global: 2,946^th place; Simple English: 848^th place)

"methamphetamine". Methamphetamine. Lexico. Archived from the original on 14 June 2021. Retrieved 22 April 2022.

nih.gov (Global: 5^th place; Simple English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Cruickshank CC, Dyer KR (July 2009). "A review of the clinical pharmacology of methamphetamine". Addiction. 104 (7): 1085–1099. doi:10.1111/j.1360-0443.2009.02564.x. PMID 19426289. S2CID 37079117.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327. S2CID 42588722.
Courtney KE, Ray LA (October 2014). "Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature". Drug Alcohol Depend. 143: 11–21. doi:10.1016/j.drugalcdep.2014.08.003. PMC 4164186. PMID 25176528.
Rau T, Ziemniak J, Poulsen D (2015). "The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury". Prog. Neuropsychopharmacol. Biol. Psychiatry. 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. ISSN 0278-5846. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).
Sellers EM, Tyndale RF (2000). "Mimicking gene defects to treat drug dependence". Ann. N. Y. Acad. Sci. 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. S2CID 27787938. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.
Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Krueger SK, Williams DE (2005). "Table 5: N-containing drugs and xenobiotics oxygenated by FMO". Pharmacology & Therapeutics. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018. Archived from the original on 16 September 2018.
Cashman JR, Xiong YN, Xu L, Janowsky A (March 1999). "N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication". J. Pharmacol. Exp. Ther. 288 (3): 1251–1260. doi:10.1016/S0022-3565(24)38081-4. PMID 10027866.

ncbi.nlm.nih.gov

Courtney KE, Ray LA (October 2014). "Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature". Drug Alcohol Depend. 143: 11–21. doi:10.1016/j.drugalcdep.2014.08.003. PMC 4164186. PMID 25176528.
Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Krueger SK, Williams DE (2005). "Table 5: N-containing drugs and xenobiotics oxygenated by FMO". Pharmacology & Therapeutics. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018. Archived from the original on 16 September 2018.

pubchem.ncbi.nlm.nih.gov

"Methamphetamine: Toxicity". PubChem Compound. National Center for Biotechnology Information. Archived from the original on 4 January 2015. Retrieved 4 January 2015.
"Methamphetamine: Chemical and Physical Properties". PubChem Compound. National Center for Biotechnology Information. Archived from the original on 4 January 2015. Retrieved 4 January 2015.

nlm.nih.gov

Heller, MD, MHA, Jacob L. (April 5, 2013). "Methamphetamine Overdose". United States National Library of Medicine. U.S. National Library of Medicine. Archived from the original on January 5, 2016. Retrieved December 31, 2015.{{cite web}}: CS1 maint: multiple names: authors list (link)

projectknow.com (Global: low place; Simple English: low place)

"What are the Dangers of Methamphetamine Abuse?". Project Know. Archived from the original on 2021-05-23. Retrieved 2021-05-23.

semanticscholar.org (Global: 15^th place; Simple English: 11^th place)

api.semanticscholar.org

Cruickshank CC, Dyer KR (July 2009). "A review of the clinical pharmacology of methamphetamine". Addiction. 104 (7): 1085–1099. doi:10.1111/j.1360-0443.2009.02564.x. PMID 19426289. S2CID 37079117.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327. S2CID 42588722.
Sellers EM, Tyndale RF (2000). "Mimicking gene defects to treat drug dependence". Ann. N. Y. Acad. Sci. 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. S2CID 27787938. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.

usdoj.gov (Global: 4,271^st place; Simple English: 2,818^th place)

deadiversion.usdoj.gov

"METHAMPHETAMINE (Trade Name: Desoxyn®; Street Names: Meth, Speed, Crystal, Glass, Ice, Crank, Yaba)" (PDF). Office of Diversion Control. United States Drug Enforcement Administration. July 2013. Archived from the original (PDF) on June 11, 2016. Retrieved April 8, 2016.

web.archive.org (Global: 1^st place; Simple English: 1^st place)

"methamphetamine". Methamphetamine. Lexico. Archived from the original on 14 June 2021. Retrieved 22 April 2022.
Anvisa (24 July 2023). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 25 July 2023). Archived from the original on 27 August 2023. Retrieved 27 August 2023.
"Methamphetamine: Toxicity". PubChem Compound. National Center for Biotechnology Information. Archived from the original on 4 January 2015. Retrieved 4 January 2015.
"Adderall XR Prescribing Information" (PDF). United States Food and Drug Administration. Shire US Inc. December 2013. pp. 12–13. Archived (PDF) from the original on 30 December 2013. Retrieved 30 December 2013.
Krueger SK, Williams DE (June 2005). "Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism". Pharmacol. Ther. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Krueger SK, Williams DE (2005). "Table 5: N-containing drugs and xenobiotics oxygenated by FMO". Pharmacology & Therapeutics. 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018. Archived from the original on 16 September 2018.
"Methamphetamine: Chemical and Physical Properties". PubChem Compound. National Center for Biotechnology Information. Archived from the original on 4 January 2015. Retrieved 4 January 2015.
"METHAMPHETAMINE (Trade Name: Desoxyn®; Street Names: Meth, Speed, Crystal, Glass, Ice, Crank, Yaba)" (PDF). Office of Diversion Control. United States Drug Enforcement Administration. July 2013. Archived from the original (PDF) on June 11, 2016. Retrieved April 8, 2016.
"NIDA – Research Report Series – Methamphetamine Abuse and Addiction". drugabuse.gov. Archived from the original on December 16, 2010. Retrieved January 22, 2011.
"DESOXYN" (PDF). accessdata.fda.gov. Food and Drug Administration. pp. 1, 7. Archived (PDF) from the original on March 11, 2011. Retrieved January 20, 2011.
"CRS Report for Congress" (PDF). house.gov. May 22, 2006. Archived from the original (PDF) on May 5, 2009. Retrieved January 20, 2011.
"NIDA – Research Report Series – Methamphetamine Abuse and Addiction". drugabuse.gov. Archived from the original on January 12, 2011. Retrieved January 22, 2011.
"Methamphetamine Fast Facts". justice.gov. Archived from the original on July 25, 2010. Retrieved January 23, 2011.
"Illinois Attorney General – Basic Understanding Of Meth". illinoisattorneygeneral.gov. Archived from the original on September 10, 2010. Retrieved January 23, 2011.
"CEWG Publications – 6/99 Seattle Advance Report – Epidemiologic Trends in Drug Abuse – NIDA". archives.drugabuse.gov. Archived from the original on August 18, 2011. Retrieved January 23, 2011.
"What are the Dangers of Methamphetamine Abuse?". Project Know. Archived from the original on 2021-05-23. Retrieved 2021-05-23.
"Effects of Meth on the Body | What Does Meth Do to Your Body?". DrugAbuse.com. Archived from the original on 2021-08-21. Retrieved 2021-08-21.
Heller, MD, MHA, Jacob L. (April 5, 2013). "Methamphetamine Overdose". United States National Library of Medicine. U.S. National Library of Medicine. Archived from the original on January 5, 2016. Retrieved December 31, 2015.{{cite web}}: CS1 maint: multiple names: authors list (link)
"WHAT IS THE LIFE EXPECTANCY OF A METHAMPHETAMINE ADDICT?". DRS. Archived from the original on 18 May 2016. Retrieved 18 January 2016.
"DrugFacts: Methamphetamine". www.drugabuse.gov. U.S. National Institute on Drug Abuse. January 2014. Archived from the original on January 2, 2016. Retrieved December 31, 2015.
"Signs of Methamphetamine use in youths – Alcohol and Drug Abuse Information – Vermont Department of Health". healthvermont.gov. Archived from the original on November 26, 2010. Retrieved January 23, 2011.

worldcat.org (Global: 4^th place; Simple English: 6^th place)

search.worldcat.org

Schep LJ, Slaughter RJ, Beasley DM (August 2010). "The clinical toxicology of metamfetamine". Clinical Toxicology. 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327. S2CID 42588722.
Rau T, Ziemniak J, Poulsen D (2015). "The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury". Prog. Neuropsychopharmacol. Biol. Psychiatry. 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. ISSN 0278-5846. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).

Methamphetamine (Simple English Wikipedia)

adsabs.harvard.edu (Global: 14th place; Simple English: 17th place)

ui.adsabs.harvard.edu

archive.org (Global: 6th place; Simple English: 3rd place)

doi.org (Global: 2nd place; Simple English: 2nd place)

drugabuse.com (Global: low place; Simple English: 8,590th place)

drugabuse.gov (Global: low place; Simple English: 1,791st place)

drugabuse.gov

archives.drugabuse.gov

drugrehab.ca (Global: low place; Simple English: low place)

fda.gov (Global: 470th place; Simple English: 788th place)

accessdata.fda.gov

healthvermont.gov (Global: low place; Simple English: low place)

house.gov (Global: 501st place; Simple English: 230th place)

illinoisattorneygeneral.gov (Global: low place; Simple English: low place)

in.gov.br (Global: 3,835th place; Simple English: 7,066th place)

justice.gov (Global: 884th place; Simple English: 644th place)

lexico.com (Global: 2,946th place; Simple English: 848th place)

nih.gov (Global: 5th place; Simple English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

nlm.nih.gov

projectknow.com (Global: low place; Simple English: low place)

semanticscholar.org (Global: 15th place; Simple English: 11th place)

api.semanticscholar.org

usdoj.gov (Global: 4,271st place; Simple English: 2,818th place)

deadiversion.usdoj.gov

web.archive.org (Global: 1st place; Simple English: 1st place)

worldcat.org (Global: 4th place; Simple English: 6th place)

search.worldcat.org

adsabs.harvard.edu (Global: 14^th place; Simple English: 17^th place)

archive.org (Global: 6^th place; Simple English: 3^rd place)

doi.org (Global: 2^nd place; Simple English: 2^nd place)

drugabuse.com (Global: low place; Simple English: 8,590^th place)

drugabuse.gov (Global: low place; Simple English: 1,791^st place)

fda.gov (Global: 470^th place; Simple English: 788^th place)

house.gov (Global: 501^st place; Simple English: 230^th place)

in.gov.br (Global: 3,835^th place; Simple English: 7,066^th place)

justice.gov (Global: 884^th place; Simple English: 644^th place)

lexico.com (Global: 2,946^th place; Simple English: 848^th place)

nih.gov (Global: 5^th place; Simple English: 5^th place)

semanticscholar.org (Global: 15^th place; Simple English: 11^th place)

usdoj.gov (Global: 4,271^st place; Simple English: 2,818^th place)

web.archive.org (Global: 1^st place; Simple English: 1^st place)

worldcat.org (Global: 4^th place; Simple English: 6^th place)